Marine Biotechnology

Marine Biotechnology

Global Marine Biotechnology Market to Reach US$12.8 Billion by 2030

The global market for Marine Biotechnology estimated at US$7.2 Billion in the year 2023, is expected to reach US$12.8 Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2023-2030. Marine Biomaterials, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$6.5 Billion by the end of the analysis period. Growth in the Marine Bioactive Substances segment is estimated at 8.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 12.0% CAGR

The Marine Biotechnology market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 12.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.4% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.5% CAGR.

Global Marine Biotechnology Market - Key Trends & Drivers Summarized

Marine biotechnology is an innovative and rapidly growing field that leverages the unique properties of marine organisms to develop new products and technologies. This interdisciplinary science harnesses the biological and chemical diversity found in marine environments to create applications in various sectors, including pharmaceuticals, cosmetics, agriculture, and environmental management. Marine organisms, such as algae, sponges, and deep-sea bacteria, produce a wide array of bioactive compounds with potential therapeutic properties. These compounds are being researched for their ability to treat diseases such as cancer, inflammation, and bacterial infections. Additionally, marine biotechnology plays a critical role in the development of sustainable aquaculture practices by providing genetic tools and biotechnological solutions to enhance the growth, health, and resilience of farmed marine species.

In the realm of environmental management, marine biotechnology offers innovative solutions for bioremediation and pollution control. Certain marine microorganisms possess the capability to degrade pollutants, such as oil spills and heavy metals, making them valuable for environmental cleanup efforts. The development of bio-based sensors and monitoring systems also allows for real-time tracking of ocean health and water quality, facilitating timely and effective response to environmental hazards. Furthermore, marine biotechnology contributes to the discovery and production of biofuels and bioplastics, promoting the use of renewable resources and reducing reliance on fossil fuels. These advancements not only support environmental sustainability but also drive economic growth by creating new markets and job opportunities in the biotechnology sector.

The growth in the marine biotechnology market is driven by several factors, including advancements in genomics and molecular biology, increasing demand for natural products, and the expanding scope of marine-derived compounds in various industries. Technological progress in DNA sequencing and bioinformatics has significantly enhanced our ability to explore and exploit marine biodiversity, leading to the discovery of novel bioactive molecules and pathways. The rising consumer preference for natural and sustainable products in pharmaceuticals and cosmetics fuels the demand for marine-sourced ingredients. Additionally, the urgent need for sustainable solutions in energy and environmental management propels the development and adoption of marine biotechnology innovations. Government initiatives and funding aimed at promoting marine research and biotechnological applications further support market growth. The confluence of these factors ensures that marine biotechnology will continue to expand, driving both scientific discovery and commercial development in the years to come.

Select Competitors (Total 224 Featured) -

• Aker BioMarine AS
• Aqua Bio Technology ASA
• BASF SE
• CP Kelco U.S., Inc.
• Cyanotech Corp.
• GlycoMar Ltd.
• Marinova Pty Ltd
• Nutrex Hawaii Inc.,
• oceanBASIS GmbH
• PharmaMar S.A
• Royal DSM N.V
• SEPPIC

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.